Ubaldo J Martin Selected Research

benralizumab

4/2024	Multivariate Cluster Analyses to Characterize Asthma Heterogeneity and Benralizumab Responsiveness.
1/2023	Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis.
1/2022	Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial.
1/2022	Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study.
1/2021	Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma.
1/2021	Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after 3 years of treatment.
1/2020	Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA).
1/2020	Blood eosinophil count group shifts and kinetics in severe eosinophilic asthma.
1/2020	Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies.
1/2020	Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ubaldo J Martin Research Topics

Disease

25	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 01/2008
16	Asthma (Bronchial Asthma) 04/2024 - 02/2012
3	Adrenal Insufficiency (Adrenal Gland Hypofunction) 12/2022 - 07/2019
3	Dyspnea (Shortness of Breath) 01/2008 - 01/2007
3	Emphysema 11/2007 - 11/2005
2	Nasal Polyps (Nasal Polyp) 01/2022 - 01/2020
2	Inflammation (Inflammations) 01/2020 - 01/2020
1	Nasal Obstruction 01/2022
1	Rhinosinusitis 01/2022
1	Airway Remodeling 01/2020
1	Infections 01/2020
1	Neoplasms (Cancer) 01/2020
1	Atherosclerosis 01/2015
1	Headache (Headaches) 08/2012
1	Nasopharyngitis 08/2012
1	Respiratory Tract Infections (Respiratory Tract Infection) 08/2012
1	Sinusitis 08/2012
1	Pneumonia (Pneumonitis) 02/2012
1	Confusion (Bewilderment) 10/2011
1	Chronic Cough 01/2007
1	Critical Illness (Critically Ill) 12/2002

Drug/Important Bio-Agent (IBA)

20	Formoterol Fumarate (Oxis)FDA Link 01/2021 - 01/2008
15	benralizumabIBA 04/2024 - 01/2019
12	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2022 - 01/2008
11	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2021 - 12/2017
9	SuspensionsIBA 01/2021 - 01/2018
9	Budesonide (Pulmicort)FDA LinkGeneric 09/2016 - 01/2008
8	Bronchodilator Agents (Bronchodilators)IBA 04/2024 - 01/2008
3	SteroidsIBA 01/2022 - 07/2019
3	Muscarinic AntagonistsIBA 01/2021 - 12/2018
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2015
3	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 12/2019 - 01/2019
3	Monoclonal AntibodiesIBA 12/2019 - 01/2019
2	Prednisone (Sone)FDA LinkGeneric 01/2022 - 07/2019
2	Fibrinogen (Factor I)FDA Link 03/2016 - 01/2015
2	apaflurane (hydrofluoroalkane)IBA 01/2009 - 01/2008
1	Prednisolone (Predate)FDA LinkGeneric 01/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022
1	GoldIBA 01/2020
1	vilanterolIBA 01/2019
1	GSK573719IBA 01/2019
1	GlucocorticoidsIBA 09/2016
1	IceIBA 01/2007

Therapy/Procedure

19	Metered Dose Inhalers (Metered Dose Inhaler) 01/2021 - 01/2008
8	Therapeutics 01/2023 - 11/2005
8	Dry Powder Inhalers 01/2019 - 01/2008
3	Pneumonectomy (Lung Volume Reduction) 11/2007 - 11/2005
1	Biological Therapy 01/2023
1	Nebulizers and Vaporizers (Inhaler) 01/2019
1	Injections 01/2019
1	Inhalation Spacers 01/2018
1	Transplantation 03/2007
1	Mechanical Ventilators (Ventilator) 12/2002
1	Critical Care (Surgical Intensive Care) 12/2002
1	Artificial Respiration (Mechanical Ventilation) 12/2002